These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 168161)
21. A case control study on immunity to two Epstein-Barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with Hodgkin's disease in Denmark, 1971-73. Hesse J; Levine PH; Ebbesen P; Connelly RR; Mordhorst CH Int J Cancer; 1977 Jan; 19(1):49-58. PubMed ID: 188770 [TBL] [Abstract][Full Text] [Related]
22. Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage. Nerurkar LS; Biggar RJ; Goedert JJ; Wallen W; Becker P; West F; Tzan N; Traub R; Lee YJ; Botelar W J Med Virol; 1987 Feb; 21(2):123-35. PubMed ID: 3029318 [TBL] [Abstract][Full Text] [Related]
23. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA). Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472 [TBL] [Abstract][Full Text] [Related]
24. Herpesvirus group antibodies in children with Hodgkin's disease. Holy J; Hrodek O; Srajer J Arch Virol; 1977; 53(3):221-33. PubMed ID: 193463 [TBL] [Abstract][Full Text] [Related]
25. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay. Hopkins RF; Witmer TJ; Neubauer RH; Rabin H J Infect Dis; 1982 Dec; 146(6):734-40. PubMed ID: 6183369 [TBL] [Abstract][Full Text] [Related]
27. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease. Bardy B; Morinet F; Pérol Y Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178 [TBL] [Abstract][Full Text] [Related]
28. Antibodies against herpesviruses in patients with Hodgkin's disease. Wutzler P; Färber I; Sprössig M; Sauerbrei A; Wutke K; Höche D; Rüdiger KD; Wöckel W; Scheibner K Arch Geschwulstforsch; 1983; 53(5):417-22. PubMed ID: 6316868 [TBL] [Abstract][Full Text] [Related]
29. A case-control study of Hodgkin's disease in Brazil II. Seroepidemiologic studies in cases and family members. Evans AS; Kirchhoff LV; Pannuti CS; Carvalho RP; McClelland KE Am J Epidemiol; 1980 Nov; 112(5):609-18. PubMed ID: 6254357 [TBL] [Abstract][Full Text] [Related]
30. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease. Stepina VN; Gourtsevicz VE; Mazurenko NP; Yarymova NM; Kaverznyeva MM; Lorye YI Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas. Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639 [TBL] [Abstract][Full Text] [Related]
32. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients. Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439 [TBL] [Abstract][Full Text] [Related]
33. Assessment of the specificity of a commercial human parvovirus B19 IgM assay. Jensen IP; Vestergaard BF Clin Diagn Virol; 1997 Feb; 7(3):133-7. PubMed ID: 9126681 [TBL] [Abstract][Full Text] [Related]
34. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. Besson C; Amiel C; Le-Pendeven C; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Abel L; Nicolas JC J Clin Microbiol; 2006 Jan; 44(1):47-50. PubMed ID: 16390946 [TBL] [Abstract][Full Text] [Related]
35. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions. Lindemalm C; Biberfeld P; Björkholm M; Henle G; Henle W; Holm G; Johansson B; Klein G; Mellstedt H Int J Cancer; 1983 Dec; 32(6):675-82. PubMed ID: 6317577 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH; Wills A; Reece E; Fox Z Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957 [TBL] [Abstract][Full Text] [Related]
38. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Shirodaria PV; Haire M; Fleming E; Merrett JD; Hawkins SA; Roberts SD Arch Neurol; 1987 Dec; 44(12):1237-41. PubMed ID: 2823754 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population. Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036 [TBL] [Abstract][Full Text] [Related]
40. Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritic patients. Nagy J; Uj M; Szücs G; Trinn C; Burger T Clin Nephrol; 1984 May; 21(5):259-62. PubMed ID: 6329570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]